Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Chinese Journal of Experimental and Clinical Virology ; (6): 345-347, 2008.
Artículo en Chino | WPRIM | ID: wpr-254062

RESUMEN

<p><b>OBJECTIVE</b>To explore the relationship between microsatellite alterations of RASSF1A gene and the development of cervical carcinoma, and HPV16 infection.</p><p><b>METHODS</b>Two sites of microsatellite polymorphism of RASSF1A gene were selected, we used polymerase chain reaction (PCR) technique to detect the LOH and MSI of cervical tissues, and to detect the infection state of HPV16.</p><p><b>RESULTS</b>There were significant differences of LOH rates at the two sites between clinical stage and pathological grade (P < 0.05). Significant differences were noted between the cervical carcinomas with lymph node metastasis and those without lymph node metastasis in regard to their LOH and MSI at the two sites ( P < 0.05). The incidence of LOH of RASSF1A gene was higher in HPV16(+) than that in HPV16(-) ( P < 0.05).</p><p><b>CONCLUSION</b>The change of RASSF1A gene is a relatively late event in cervical carcinomas. The detection of the LOH and MSI of RASSF1A gene might be helpful to the early diagnosis and the screening of cervical carcinoma. It might also be useful for predicting the prognosis of cervical carcinoma. Infection of HPV16 and LOH of RASSF1A gene had reacted together in the development of cervical carcinoma.</p>


Asunto(s)
Femenino , Humanos , Displasia del Cuello del Útero , Diagnóstico , Genética , Regulación Neoplásica de la Expresión Génica , Pérdida de Heterocigocidad , Genética , Repeticiones de Microsatélite , Genética , Nucleósido Difosfato Quinasas NM23 , Genética , Proteínas Supresoras de Tumor , Genética , Neoplasias del Cuello Uterino , Diagnóstico , Genética
2.
Chinese Medical Journal ; (24): 1247-1250, 2007.
Artículo en Inglés | WPRIM | ID: wpr-280458

RESUMEN

<p><b>BACKGROUND</b>Inhibition of the key costimulatory signals results in T cell anergy, indicating the alloantigen-specific immunologic unresponsiveness. In this study, the effect of blockage of costimulatory signal CD(86) on murine abortion-prone model was studied.</p><p><b>METHODS</b>Thirty CBA/J female mice cohabitated with DBA/2 male or BALB/c male mice were investigated. CBA/J x DBA/2 matings were used as the abortion-prone model, and CBA/J x BALB/c matings were used as the normal pregnant model. The abortion-prone models were divided into experimental and control groups, and the normal pregnant models were set as a normal group (10 mice in each group). The mice in the experimental group were treated with anti-mouse CD(86) monoclonal antibody (mAb) (100 microg) on day 4.5 of gestation, while the controls received irrelevant-isotype matched rat IgG(2b). As for the normal group, nothing was given to the mice. The mice were killed on day 13.5 of gestation, embryo resorption rate and the expression of transforming growth factor beta(1) (TGF-beta(1)), plasminogen activator inhibitor 1 (PAI-1), and matrix metalloproteinase 9 (MMP-9) were detected. Then the data were analyzed by Chi-square test and Fisher's exact test.</p><p><b>RESULTS</b>The embryo resorption rate in the experimental (8.2%) and normal groups (7.7%) was significantly lower than that of the control (23.5%, P < 0.05). No significant difference was detected between the experimental and normal groups (P > 0.05). The positive expression rates of TGF-beta(1) and PAI-1 proteins in the experimental and normal groups were significantly higher than those in the control group (P < 0.05). The positive expression rate of MMP-9 protein in the experimental and normal groups was significantly lower than that in the control group (P < 0.05). No significant difference in the positive expression rates of the three proteins was detected between the experimental and normal groups (P > 0.05).</p><p><b>CONCLUSIONS</b>Blockage of costimulatory signal CD(86) at early pregnancy can treat uncertain recurrent spontaneous abortion by stimulating the expression of TGF-beta(1), MMP-9 and PAI-1 and reducing the embryo resorption rate.</p>


Asunto(s)
Animales , Femenino , Masculino , Ratones , Embarazo , Aborto Habitual , Terapéutica , Anticuerpos Monoclonales , Usos Terapéuticos , Antígeno B7-2 , Alergia e Inmunología , Fisiología , Pérdida del Embrión , Inmunohistoquímica , Metaloproteinasa 9 de la Matriz , Ratones Endogámicos , Inhibidor 1 de Activador Plasminogénico , Transducción de Señal , Factor de Crecimiento Transformador beta1
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA